Monday, June 8, 2026

North Korea’s Bold Statement on U.S. and Israel’s Actions: What This Means for Middle East Peace

North Korea condemned U.S. and Israeli military actions against Iran as unlawful aggression, warning of severe geopolitical repercussions.

Private Lineage Server Operator gets 1-year Prison Term for Dealings with North Korean Developer

A South Korean court sentenced a man to one year in prison for operating an illegal game server linked to North Korean hacking activities.

China’s 5-Minute EV Charging Revolution: How BYD’s Technology Leaves the U.S. Behind

China leads in EV charging tech with 70% charge in 5 mins, while the U.S. boosts infrastructure amid sales challenges.

Yu Ri Cho

Author's Latest

Samsung’s G-CROWN Platform is Revolutionizing Gene Therapy for Rare Diseases in Asia

Samsung Medical Center launches G-CROWN platform to develop gene therapies for rare diseases, aiming to reduce reliance on imports.

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

AITRICS establishes first AI ethics checklist in healthcare

AITRICS develops the first AI ethics checklist for healthcare, ensuring compliance with ethical standards in medical AI applications.

Coreline Soft Secures Major AI Contract with Italy’s National Cancer Center for Lung Cancer Early Detection

Coreline Soft renews its contract for AVIEW LCS Plus with Italy's National Cancer Center, enhancing early lung cancer diagnosis via AI.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

22,700 Deaths Highlight a Growing Antibiotic Resistance Crisis

Antibiotic resistance poses a severe threat, especially in nursing homes. Awareness and reduced usage are crucial to combat this growing crisis.

CG MedTech Acquires Human Tissue Processing Bank: What This Means for the Bio Sector in 2026

CG MedTech acquires a human tissue processing bank, expanding into bio business with ECM-based therapeutics and dental materials.

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

GC Biopharma Develops Innovative Method to Enhance Immunoglobulin Safety

GC녹십자 developed a method to detect impurities that can cause blood clots in the production of intravenous immunoglobulin.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.